clostridium novyi-nt spores
Cell therapyexperimental
Clinical trial activity
5 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2006 (NCT00358397)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- clostridium novyi-nt spores
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05693077 | Phase 1 | Sep 22, 2023 | Leiden University |
| NCT03435952 | Phase 1 | Jul 10, 2018 | BioMed Valley Discoveries, Inc, Merck, University of Texas at Houston |
| NCT01924689 | Phase 1 | Oct 1, 2013 | BioMed Valley Discoveries, Inc |
| NCT01118819 | Phase 1 | Apr 1, 2011 | BioMed Valley Discoveries, Inc |
| NCT00358397 | Phase 1 | Jul 1, 2006 | Johns Hopkins University |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BioMed Valley Discoveries, Inc | For profit | 3 | 2 | 1 | 2011 |
| Johns Hopkins University | Academic/Hospital | 1 | 1 | 1 | 2006 |
| Leiden University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Merck | For profit | 1 | 0 | 1 | 2018 |
| University of Texas at Houston | Academic/Hospital | 1 | 1 | 1 | 2018 |
5 organizations
Page 1 / 1